$328.54
0[0.00%]
At close: Apr 23
$328.54
0[0.00%]
PreMarket: 4:17PM EDT
Shockwave Medical
(NASDAQ:SWAV)Shockwave Medical Stock (NASDAQ:SWAV), Analyst Ratings, Price Targets, Predictions
Shockwave Medical Inc has a consensus price target of $228.76, established from looking at the 66 latest analyst ratings. The last 3 analyst ratings were released from CL King, Leerink Partners, and Deutsche Bank on April 8, 2024. With an average price target of $223.33 between CL King, Leerink Partners, and Deutsche Bank, there's an implied -32.02% downside for Shockwave Medical Inc from these 3 analyst ratings.
Analyst Firms Making Recommendations1
CL King
Leerink Partners
Deutsche Bank
Morgan Stanley
Canaccord Genuity
1calculated from analyst ratings published within the last 3 years
Analyst Ratings for Shockwave Medical
date | ticker | Buy Now | Company | Current price | Upside/Downside | Analyst Firm | Analyst & % Accurate | Price Target Change | Rating Change | Previous / Current Rating | Get Alert |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 04/08/2024 | SWAV | Buy Now | Shockwave Medical | $328.54 | — | CL King | Kristen Stewart | — | Downgrade | Buy → Neutral | Get Alert |
| 04/08/2024 | SWAV | Buy Now | Shockwave Medical | $328.54 | 1.97% | Leerink Partners | Mike Kratky | $361 → $335 | Downgrade | Outperform → Market Perform | Get Alert |
| 04/08/2024 | SWAV | Buy Now | Shockwave Medical | $328.54 | 1.97% | Deutsche Bank | Imron Zafar | $270 → $335 | Downgrade | Buy → Hold | Get Alert |
| 04/08/2024 | SWAV | Buy Now | Shockwave Medical | $328.54 | 1.97% | Morgan Stanley | Patrick Wood | $285 → $335 | Downgrade | Overweight → Equal-Weight | Get Alert |
| 04/05/2024 | SWAV | Buy Now | Shockwave Medical | $328.54 | 1.97% | Canaccord Genuity | William Plovanic | $263 → $335 | Downgrade | Buy → Hold | Get Alert |
| 04/05/2024 | SWAV | Buy Now | Shockwave Medical | $328.54 | — | Needham | Mike Matson | — | Downgrade | Buy → Hold | Get Alert |
| 04/05/2024 | SWAV | Buy Now | Shockwave Medical | $328.54 | — | Wolfe Research | Mike Polark | — | Downgrade | Outperform → Peer Perform | Get Alert |
| 04/02/2024 | SWAV | Buy Now | Shockwave Medical | $328.54 | 9.58% | Piper Sandler | Adam Maeder | $290 → $360 | Maintains | Overweight | Get Alert |
| 03/27/2024 | SWAV | Buy Now | Shockwave Medical | $328.54 | 12.01% | CL King | — | → $368 | Initiates | → Buy | Get Alert |
| 02/16/2024 | SWAV | Buy Now | ShockWave Medical | $328.54 | -36.08% | Wells Fargo | Larry Biegelsen | $200 → $210 | Maintains | Equal-Weight | Get Alert |
| 02/16/2024 | SWAV | Buy Now | ShockWave Medical | $328.54 | -11.73% | Piper Sandler | Adam Maeder | $275 → $290 | Maintains | Overweight | Get Alert |
| 02/16/2024 | SWAV | Buy Now | ShockWave Medical | $328.54 | -12.95% | Needham | Mike Matson | $260 → $286 | Maintains | Buy | Get Alert |
| 12/04/2023 | SWAV | Buy Now | ShockWave Medical | $328.54 | -32.12% | Morgan Stanley | Patrick Wood | $284 → $223 | Maintains | Overweight | Get Alert |
| 11/07/2023 | SWAV | Buy Now | ShockWave Medical | $328.54 | -13.56% | Morgan Stanley | Patrick Wood | $313 → $284 | Maintains | Overweight | Get Alert |
| 11/07/2023 | SWAV | Buy Now | ShockWave Medical | $328.54 | -20.86% | Needham | Mike Matson | $265 → $260 | Maintains | Buy | Get Alert |
| 10/24/2023 | SWAV | Buy Now | ShockWave Medical | $328.54 | -19.34% | Needham | Mike Matson | $330 → $265 | Maintains | Buy | Get Alert |
| 10/16/2023 | SWAV | Buy Now | ShockWave Medical | $328.54 | -19.95% | Leerink Partners | Mike Kratky | → $263 | Initiates | → Outperform | Get Alert |
| 09/29/2023 | SWAV | Buy Now | ShockWave Medical | $328.54 | -33.65% | UBS | Danielle Antalffy | → $218 | Initiates | → Neutral | Get Alert |
| 08/10/2023 | SWAV | Buy Now | ShockWave Medical | $328.54 | -4.73% | Morgan Stanley | Patrick Wood | $335 → $313 | Maintains | Overweight | Get Alert |
FAQ
What is the target price for Shockwave Medical (SWAV)?
The latest price target for Shockwave Medical (NASDAQ: SWAV) was reported by CL King on April 8, 2024. The analyst firm set a price target for $0.00 expecting SWAV to fall to within 12 months (a possible -100.00% downside). 30 analyst firms have reported ratings in the last year.
What is the most recent analyst rating for Shockwave Medical (SWAV)?
The latest analyst rating for Shockwave Medical (NASDAQ: SWAV) was provided by CL King, and Shockwave Medical downgraded their neutral rating.
When was the last upgrade for Shockwave Medical (SWAV)?
The last upgrade for Shockwave Medical Inc happened on July 10, 2023 when Morgan Stanley raised their price target to $335. Morgan Stanley previously had an equal-weight for Shockwave Medical Inc.
When was the last downgrade for Shockwave Medical (SWAV)?
The last downgrade for Shockwave Medical Inc happened on April 8, 2024 when CL King changed their price target from N/A to N/A for Shockwave Medical Inc.
When is the next analyst rating going to be posted or updated for Shockwave Medical (SWAV)?
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Shockwave Medical, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Shockwave Medical was filed on April 8, 2024 so you should expect the next rating to be made available sometime around April 8, 2025.
Is the Analyst Rating Shockwave Medical (SWAV) correct?
While ratings are subjective and will change, the latest Shockwave Medical (SWAV) rating was a downgraded with a price target of $0.00 to $0.00. The current price Shockwave Medical (SWAV) is trading at is $328.54, which is out of the analyst’s predicted range.
Browse analyst ratings and price targets on all stocks.